Leonardo DRS, Inc. (DRS) Balance Sheet

The sequential increase in equity, from $2.4B in 2024Q1 to $2.8B in 2026Q2, reflects cumulative profitability despite negative retained earnings, which improved from -$2.8B to -$2.2B. This suggests that the company is generating sufficient earnings to offset historical losses, a sign of improving financial health. The reduction in total debt from $484M to $149M over the same period further supports a deleveraging trend, enhancing the balance sheet's resilience.

The dramatic reduction in debt, from $484M to $149M, while equity rose, has pushed leverage to negligible levels. This appears to be a deliberate strategy to maintain a fortress balance sheet, providing dry powder for future M&A or R&D investments. The low leverage also insulates the company from interest rate fluctuations, a key advantage in a rising rate environment, and suggests that debt is not a strategic necessity but rather a manageable component of the capital structure.

The consistent goodwill balance suggests that acquisitions, such as RADA, have not led to impairment, but the large proportion of intangibles relative to tangible assets warrants monitoring for potential write-downs if growth expectations falter. The increase in PPE, from $407M to $526M, reflects ongoing investment in specialized testing facilities and manufacturing capabilities, aligning with the company's focus on high-tech defense electronics. This asset mix is characteristic of an asset-light model with high barriers to entry, but the reliance on goodwill and intangibles introduces valuation risk.

The improvement in retained earnings, despite still being negative, suggests that the company is generating consistent profits that are being reinvested, rather than distributed. The initiation of dividends and modest share repurchases, as noted in prior cash flow analysis, indicates a balanced approach to capital returns, but the negative retained earnings highlight the legacy of past losses. Investors should monitor whether the company can continue to build equity through earnings, as this will be crucial for long-term financial stability.

The current ratio has remained consistently above 1.8 over the past ten quarters, providing a comfortable cushion against short-term liabilities. Cash levels fluctuate significantly, from $149M in 2024Q2 to $647M in 2025Q4, reflecting working capital swings, but the overall liquidity position appears robust. This buffer is essential given the lumpy nature of defense contract cash flows, and it supports the company's ability to invest in growth while maintaining financial flexibility.

The steady increase in deferred revenue, particularly the jump from $440M in 2025Q3 to $598M in 2026Q2, aligns with the record backlog and bookings momentum highlighted in recent earnings. This suggests that customers are prepaying for long-term contracts, providing a degree of revenue visibility that is uncommon in many industries. However, the volatility in deferred revenue, with a dip to $315M in 2024Q3, underscores the lumpiness of defense contract timing, and investors should monitor this metric for signs of sustained demand.